4//SEC Filing
Dmytruk Mark E. 4
Accession 0001127602-25-015297
CIK 0001830214other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:05 PM ET
Size
16.4 KB
Accession
0001127602-25-015297
Insider Transaction Report
Form 4
Dmytruk Mark E.
See remarks
Transactions
- Exercise/Conversion
Class A Common Stock
2025-05-20+453→ 46,360 total - Exercise/Conversion
Class A Common Stock
2025-05-20+572→ 46,932 total - Exercise/Conversion
Restricted Stock Units
2025-05-20−453→ 9,970 total→ Class A Common Stock (453 underlying) - Exercise/Conversion
Class A Common Stock
2025-05-20+454→ 45,907 total - Sale
Class A Common Stock
2025-05-21$7.58/sh−706$5,355→ 46,226 total - Exercise/Conversion
Restricted Stock Units
2025-05-20−454→ 3,614 total→ Class A Common Stock (454 underlying) - Exercise/Conversion
Restricted Stock Units
2025-05-20−572→ 19,488 total→ Class A Common Stock (572 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
- [F3]The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
- [F4]The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.
Documents
Issuer
Ginkgo Bioworks Holdings, Inc.
CIK 0001830214
Entity typeother
Related Parties
1- filerCIK 0001873507
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:05 PM ET
- Size
- 16.4 KB